- Home
- Publications
- Publication Search
- Publication Details
Title
Lung cancer patients with COVID-19 in Spain: GRAVID study
Authors
Keywords
COVID-19, Lung cancer, Mortality, Anticancer therapy, Prognosis
Journal
LUNG CANCER
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-14
DOI
10.1016/j.lungcan.2021.05.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
- (2020) H. Miyashita et al. ANNALS OF ONCOLOGY
- Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival.
- (2020) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic
- (2020) Sameera Kumar et al. Journal of Thoracic Oncology
- Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
- (2020) Anne-Marie C. Dingemans et al. Journal of Thoracic Oncology
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
- (2020) Kunyu Yang et al. LANCET ONCOLOGY
- A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 ( COVID ‐19) Pandemic: An International Collaborative Group
- (2020) Humaid O. Al‐Shamsi et al. ONCOLOGIST
- Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID ‐19 epidemic
- (2020) Zhe Zhao et al. Thoracic Cancer
- Non-steroidal anti-inflammatory drugs and covid-19
- (2020) Paul Little BMJ-British Medical Journal
- Consensus statement: summary of the Quebec Lung Cancer Network recommendations for prioritizing patients with thoracic cancers in the context of the COVID-19 pandemic
- (2020) N. Blais et al. Current Oncology
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Determinants of COVID-19 disease severity in patients with cancer
- (2020) Elizabeth V. Robilotti et al. NATURE MEDICINE
- COVID-19 and Cancer: Current Challenges and Perspectives
- (2020) Ziad Bakouny et al. CANCER CELL
- Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID‐19 pandemic: the THOCOoP cooperative group
- (2020) Oscar Arrieta et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
- (2020) K. de Joode et al. EUROPEAN JOURNAL OF CANCER
- Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)
- (2020) Astrid Lièvre et al. EUROPEAN JOURNAL OF CANCER
- Corticosteroids in COVID-19 ARDS
- (2020) Hallie C. Prescott et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chemotherapy and COVID-19 Outcomes in Patients With Cancer
- (2020) Justin Jee et al. JOURNAL OF CLINICAL ONCOLOGY
- COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started